Francisca F. De Sousa
Fortaleza, CE, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Antidepressant-like effect of riparin I and riparin II against CUMS-induced neuroinflammation via astrocytes and microglia modulation in mice.
Journal: Behavioural pharmacology
Published: July 22, 2024
Carvacrol alleviates CUMS-induced depressive-like behaviors and cognitive impairment by reducing oxidative stress and neuroinflammation in mice.
Journal: Behavioural brain research
Published: April 29, 2024
Cyclooxygenase-2 inhibitors alleviated depressive and anxious-like behaviors in mice exposed to lipopolysaccharide: Involvement of oxidative stress and neuroinflammation.
Journal: Pharmacology, biochemistry, and behavior
Published: February 02, 2024
Long-term Environmental Enrichment Normalizes Schizophrenia-like Abnormalities and Promotes Hippocampal Slc6a4 Promoter Demethylation in Mice Submitted to a Two-hit Model.
Journal: Neuroscience
Published: January 02, 2024
Long-term administration of omeprazole in mice: a study of behavior, inflammatory, and oxidative stress alterations with focus on central nervous system.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: August 30, 2023
Neuroprotective effects of dimethyl fumarate against depression-like behaviors via astrocytes and microglia modulation in mice: possible involvement of the HCAR2/Nrf2 signaling pathway.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: February 18, 2022
Involvement of anti-inflammatory, antioxidant, and BDNF up-regulating properties in the antipsychotic-like effect of the essential oil of Alpinia zerumbet in mice: a comparative study with olanzapine.
Journal: Metabolic brain disease
Published: February 17, 2021
Animal Model of Neonatal Immune Challenge by Lipopolysaccharide: A Study of Sex Influence in Behavioral and Immune/Neurotrophic Alterations in Juvenile Mice.
Journal: Neuroimmunomodulation
Published: October 16, 2020
Is Riparin III a promising drug in the treatment for depression?
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: May 30, 2020
The neuroprotective effect of Riparin IV on oxidative stress and neuroinflammation related to chronic stress-induced cognitive impairment.
Journal: Hormones and behavior
Published: October 03, 2019
Thymol reverses depression-like behaviour and upregulates hippocampal BDNF levels in chronic corticosterone-induced depression model in female mice.
Journal: The Journal of pharmacy and pharmacology
Published: July 03, 2019
High Exploratory Phenotype Rats Exposed to Environmental Stressors Present Memory Deficits Accompanied by Immune-Inflammatory/Oxidative Alterations: Relevance to the Relationship Between Temperament and Mood Disorders.
Journal: Frontiers in psychiatry
Published: April 08, 2019
Last Updated: 09/26/2026